Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1895246

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1895246

Growth Factors Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
PDF & Excel (Multi User License)
USD 7295
PDF & Excel (Corporate User License)
USD 8495

Add to Cart

Description

Table of Contents

Persistence Market Research has published a detailed analysis of the global growth factors market. The report provides an in-depth assessment of key market dynamics, including growth drivers, emerging trends, opportunities, and constraints, offering clear insights into how the growth factors industry is evolving across pharmaceutical, biotechnology, and research sectors worldwide.

Key Market Insights

  • Growth Factors Market Size (2025A): US$ 2.4 Bn
  • Estimated Market Value (2032F): US$ 3.5 Bn
  • Global Market Growth Rate (CAGR 2025-2032): 5.7%

Growth Factors Market - Report Scope

The global growth factors market encompasses a broad range of naturally occurring and recombinant proteins that regulate cellular processes such as proliferation, differentiation, migration, and survival. These bioactive molecules are widely utilized across oncology, hematology, wound healing, dermatology, cardiovascular disease, diabetes treatment, cell therapy, and ex-vivo manufacturing. Rising investments in biotechnology, regenerative medicine, and personalized therapies are driving demand for high-quality growth factors.

Market Growth Drivers

The market is largely propelled by the increasing prevalence of chronic diseases, growing focus on regenerative medicine, and expansion of cell and gene therapies. Rising R&D activities in biotechnology, coupled with innovations in recombinant protein technologies, have significantly increased the availability and scalability of growth factors.

Supportive government initiatives, favorable regulatory frameworks, and rising adoption of biologics in clinical applications further contribute to market growth. Additionally, advancements in bio-manufacturing techniques, including recombinant protein expression systems and improved purification technologies, are enhancing product efficacy and reducing costs.

Market Restraints

Despite steady growth, challenges remain. High production costs, stringent regulatory compliance, and quality assurance requirements limit market entry for small-scale manufacturers. Furthermore, the complex nature of protein stability, storage conditions, and shorter shelf life of biologically active molecules pose logistical hurdles.

Limited awareness and adoption in certain emerging markets, along with the need for skilled professionals to handle sensitive biologics, also constrain growth. Companies are increasingly investing in training, scalable manufacturing solutions, and quality management systems to overcome these barriers.

Market Opportunities

Emerging applications in precision medicine, immunotherapy, and tissue engineering offer significant growth potential. Increasing collaboration between pharmaceutical companies, contract research organizations (CROs), and academic institutions is creating avenues for innovation and product development.

Expanding applications in rare diseases, oncology, and chronic wound management, as well as rising investments in recombinant protein technologies, present lucrative opportunities. Emerging regions such as South Asia, Latin America, and parts of East Asia offer untapped potential due to growing healthcare infrastructure, biotechnology investments, and research initiatives.

Key Questions Answered in the Report

  • Which growth factors are experiencing the fastest adoption across therapeutic areas?
  • How do recombinant and animal-derived expression systems compare in terms of market penetration?
  • Which applications and end users are driving the highest demand?
  • What impact do regulatory frameworks have on market growth?
  • Which regions are expected to offer the most promising growth opportunities from 2025 to 2032?

Competitive Intelligence and Business Strategy

Key players in the growth factors market focus on continuous innovation, expanding R&D capabilities, and strategic partnerships with biotechnology firms, research institutions, and contract manufacturers. Companies are emphasizing the development of recombinant proteins, scalable production systems, and high-purity formulations to enhance market competitiveness.

Strategic initiatives such as acquisitions, licensing agreements, and global distribution partnerships are common approaches to strengthen product portfolios and geographic reach. Additionally, certifications such as GMP compliance and ISO standards are being leveraged to ensure product quality, safety, and regulatory compliance.

Growth Factors Market Segmentation

By Product

  • Transforming Growth Factors (TGF)
  • Activin
  • Bone Morphogenetic Proteins (BMPs)
  • TGF-beta Proteins
  • Epidermal Growth Factors (EGFs)
  • Platelet-derived Growth Factors (PDGFs)
  • Fibroblast Growth Factors (FGFs)
  • Insulin-like Growth Factors (IGFs)
  • Vascular Endothelial Growth Factors (VEGFs)
  • Hepatocyte Growth Factors (HGFs)
  • Tumor Necrosis Factors (TNFs)
  • Interleukins
  • Others

By Grade

  • GMP Grade
  • NON-GMP Grade

By Application

  • Oncology
  • Hematology
  • Wound Healing
  • Dermatology
  • Cardiovascular Disease and Diabetes
  • Cell Therapy and Ex-vivo Manufacturing
  • Others

By Expression Host System

  • Animal-derived
  • Recombinant

By Mode of Action

  • Angiogenic
  • Anti-apoptotic
  • Mitogenic

By Species Origin

  • Human
  • Pig
  • Mouse
  • Rat
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Research Centers and Academic Institutes
  • Contract Research Organizations

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa
Show more
Product Code: PMRREP4456

Table of Contents

1. Executive Summary

  • 1.1. Global Growth Factors Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Growth Factors Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Growth Factors Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      • 4.3.3.1. Transforming Growth Factors (TGF)
        • 4.3.3.1.1. Activin
        • 4.3.3.1.2. Bone Morphogenetic Proteins (BMPs)
        • 4.3.3.1.3. TGF-beta Proteins
      • 4.3.3.2. Epidermal Growth Factors (EGFs)
      • 4.3.3.3. Platelet-derived Growth Factors (PDGFs)
      • 4.3.3.4. Fibroblast Growth Factors (FGFs)
      • 4.3.3.5. Insulin-like Growth Factors (IGFs)
      • 4.3.3.6. Vascular Endothelial Growth Factors (VEGFs)
      • 4.3.3.7. Hepatocyte Growth Factors (HGFs)
      • 4.3.3.8. Tumor Necrosis Factors (TNFs)
      • 4.3.3.9. Interleukins
      • 4.3.3.10. Others
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global Growth Factors Market Outlook: Grade
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Grade, 2019 - 2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 - 2032
      • 4.4.3.1. GMP Grade
      • 4.4.3.2. NON-GMP Grade
    • 4.4.4. Market Attractiveness Analysis: Grade
  • 4.5. Global Growth Factors Market Outlook: Application
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      • 4.5.3.1. Oncology
      • 4.5.3.2. Hematology
      • 4.5.3.3. Wound Healing
      • 4.5.3.4. Dermatology
      • 4.5.3.5. Cardiovascular Disease and Diabetes
      • 4.5.3.6. Cell Therapy and EX-vivo Manufacturing
      • 4.5.3.7. Others
    • 4.5.4. Market Attractiveness Analysis: Application
  • 4.6. Global Growth Factors Market Outlook: Expression Host System
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Mn) Analysis, By Expression Host System, 2019 - 2024
    • 4.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Expression Host System, 2025 - 2032
      • 4.6.3.1. Animal-derived
      • 4.6.3.2. Recombinant
    • 4.6.4. Market Attractiveness Analysis: Expression Host System
  • 4.7. Global Growth Factors Market Outlook: Mode of Action
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis, By Mode of Action, 2019 - 2024
    • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 - 2032
      • 4.7.3.1. Angiogenic
      • 4.7.3.2. Anti-apoptotic
      • 4.7.3.3. Mitogenic
    • 4.7.4. Market Attractiveness Analysis: Mode of Action
  • 4.8. Global Growth Factors Market Outlook: Species Origin
    • 4.8.1. Introduction / Key Findings
    • 4.8.2. Historical Market Size (US$ Mn) Analysis, By Species Origin, 2019 - 2024
    • 4.8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 - 2032
      • 4.8.3.1. Human
      • 4.8.3.2. Pig
      • 4.8.3.3. Mouse
      • 4.8.3.4. Rat
    • 4.8.4. Market Attractiveness Analysis: Species Origin
  • 4.9. Global Growth Factors Market Outlook: End User
    • 4.9.1. Introduction / Key Findings
    • 4.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
    • 4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      • 4.9.3.1. Pharmaceutical and Biotechnology Companies
      • 4.9.3.2. Research Centers and Academic Institutes
      • 4.9.3.3. Contract Research Organizations
    • 4.9.4. Market Attractiveness Analysis: End User

5. Global Growth Factors Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Growth Factors Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Grade
    • 6.2.4. By Application
    • 6.2.5. By Expression Host System
    • 6.2.6. By Mode of Action
    • 6.2.7. By Species Origin
    • 6.2.8. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
    • 6.4.1. Transforming Growth Factors (TGF)
      • 6.4.1.1. Activin
      • 6.4.1.2. Bone Morphogenetic Proteins (BMPs)
      • 6.4.1.3. TGF-beta Proteins
    • 6.4.2. Epidermal Growth Factors (EGFs)
    • 6.4.3. Platelet-derived Growth Factors (PDGFs)
    • 6.4.4. Fibroblast Growth Factors (FGFs)
    • 6.4.5. Insulin-like Growth Factors (IGFs)
    • 6.4.6. Vascular Endothelial Growth Factors (VEGFs)
    • 6.4.7. Hepatocyte Growth Factors (HGFs)
    • 6.4.8. Tumor Necrosis Factors (TNFs)
    • 6.4.9. Interleukins
    • 6.4.10. Others
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 - 2032
    • 6.5.1. GMP Grade
    • 6.5.2. NON-GMP Grade
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 6.6.1. Oncology
    • 6.6.2. Hematology
    • 6.6.3. Wound Healing
    • 6.6.4. Dermatology
    • 6.6.5. Cardiovascular Disease and Diabetes
    • 6.6.6. Cell Therapy and EX-vivo Manufacturing
    • 6.6.7. Others
  • 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 - 2032
    • 6.7.1. Animal-derived
    • 6.7.2. Recombinant
  • 6.8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 - 2032
    • 6.8.1. Angiogenic
    • 6.8.2. Anti-apoptotic
    • 6.8.3. Mitogenic
  • 6.9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 - 2032
    • 6.9.1. Human
    • 6.9.2. Pig
    • 6.9.3. Mouse
    • 6.9.4. Rat
    • 6.9.5. Others
  • 6.10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    • 6.10.1. Pharmaceutical and Biotechnology Companies
    • 6.10.2. Research Centers and Academic Institutes
    • 6.10.3. Contract Research Organizations
  • 6.11. Market Attractiveness Analysis

7. Europe Growth Factors Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Grade
    • 7.2.4. By Application
    • 7.2.5. By Expression Host System
    • 7.2.6. By Mode of Action
    • 7.2.7. By Species Origin
    • 7.2.8. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkiye
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
    • 7.4.1. Transforming Growth Factors (TGF)
      • 7.4.1.1. Activin
      • 7.4.1.2. Bone Morphogenetic Proteins (BMPs)
      • 7.4.1.3. TGF-beta Proteins
    • 7.4.2. Epidermal Growth Factors (EGFs)
    • 7.4.3. Platelet-derived Growth Factors (PDGFs)
    • 7.4.4. Fibroblast Growth Factors (FGFs)
    • 7.4.5. Insulin-like Growth Factors (IGFs)
    • 7.4.6. Vascular Endothelial Growth Factors (VEGFs)
    • 7.4.7. Hepatocyte Growth Factors (HGFs)
    • 7.4.8. Tumor Necrosis Factors (TNFs)
    • 7.4.9. Interleukins
    • 7.4.10. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 - 2032
    • 7.5.1. GMP Grade
    • 7.5.2. NON-GMP Grade
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 7.6.1. Oncology
    • 7.6.2. Hematology
    • 7.6.3. Wound Healing
    • 7.6.4. Dermatology
    • 7.6.5. Cardiovascular Disease and Diabetes
    • 7.6.6. Cell Therapy and EX-vivo Manufacturing
    • 7.6.7. Others
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 - 2032
    • 7.7.1. Animal-derived
    • 7.7.2. Recombinant
  • 7.8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 - 2032
    • 7.8.1. Angiogenic
    • 7.8.2. Anti-apoptotic
    • 7.8.3. Mitogenic
  • 7.9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 - 2032
    • 7.9.1. Human
    • 7.9.2. Pig
    • 7.9.3. Mouse
    • 7.9.4. Rat
    • 7.9.5. Others
  • 7.10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    • 7.10.1. Pharmaceutical and Biotechnology Companies
    • 7.10.2. Research Centers and Academic Institutes
    • 7.10.3. Contract Research Organizations
  • 7.11. Market Attractiveness Analysis

8. East Asia Growth Factors Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Grade
    • 8.2.4. By Application
    • 8.2.5. By Expression Host System
    • 8.2.6. By Mode of Action
    • 8.2.7. By Species Origin
    • 8.2.8. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
    • 8.4.1. Transforming Growth Factors (TGF)
      • 8.4.1.1. Activin
      • 8.4.1.2. Bone Morphogenetic Proteins (BMPs)
      • 8.4.1.3. TGF-beta Proteins
    • 8.4.2. Epidermal Growth Factors (EGFs)
    • 8.4.3. Platelet-derived Growth Factors (PDGFs)
    • 8.4.4. Fibroblast Growth Factors (FGFs)
    • 8.4.5. Insulin-like Growth Factors (IGFs)
    • 8.4.6. Vascular Endothelial Growth Factors (VEGFs)
    • 8.4.7. Hepatocyte Growth Factors (HGFs)
    • 8.4.8. Tumor Necrosis Factors (TNFs)
    • 8.4.9. Interleukins
    • 8.4.10. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 - 2032
    • 8.5.1. GMP Grade
    • 8.5.2. NON-GMP Grade
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 8.6.1. Oncology
    • 8.6.2. Hematology
    • 8.6.3. Wound Healing
    • 8.6.4. Dermatology
    • 8.6.5. Cardiovascular Disease and Diabetes
    • 8.6.6. Cell Therapy and EX-vivo Manufacturing
    • 8.6.7. Others
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 - 2032
    • 8.7.1. Animal-derived
    • 8.7.2. Recombinant
  • 8.8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 - 2032
    • 8.8.1. Angiogenic
    • 8.8.2. Anti-apoptotic
    • 8.8.3. Mitogenic
  • 8.9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 - 2032
    • 8.9.1. Human
    • 8.9.2. Pig
    • 8.9.3. Mouse
    • 8.9.4. Rat
    • 8.9.5. Others
  • 8.10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    • 8.10.1. Pharmaceutical and Biotechnology Companies
    • 8.10.2. Research Centers and Academic Institutes
    • 8.10.3. Contract Research Organizations
  • 8.11. Market Attractiveness Analysis

9. South Asia & Oceania Growth Factors Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Grade
    • 9.2.4. By Application
    • 9.2.5. By Expression Host System
    • 9.2.6. By Mode of Action
    • 9.2.7. By Species Origin
    • 9.2.8. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
    • 9.4.1. Transforming Growth Factors (TGF)
      • 9.4.1.1. Activin
      • 9.4.1.2. Bone Morphogenetic Proteins (BMPs)
      • 9.4.1.3. TGF-beta Proteins
    • 9.4.2. Epidermal Growth Factors (EGFs)
    • 9.4.3. Platelet-derived Growth Factors (PDGFs)
    • 9.4.4. Fibroblast Growth Factors (FGFs)
    • 9.4.5. Insulin-like Growth Factors (IGFs)
    • 9.4.6. Vascular Endothelial Growth Factors (VEGFs)
    • 9.4.7. Hepatocyte Growth Factors (HGFs)
    • 9.4.8. Tumor Necrosis Factors (TNFs)
    • 9.4.9. Interleukins
    • 9.4.10. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 - 2032
    • 9.5.1. GMP Grade
    • 9.5.2. NON-GMP Grade
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 9.6.1. Oncology
    • 9.6.2. Hematology
    • 9.6.3. Wound Healing
    • 9.6.4. Dermatology
    • 9.6.5. Cardiovascular Disease and Diabetes
    • 9.6.6. Cell Therapy and EX-vivo Manufacturing
    • 9.6.7. Others
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 - 2032
    • 9.7.1. Animal-derived
    • 9.7.2. Recombinant
  • 9.8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 - 2032
    • 9.8.1. Angiogenic
    • 9.8.2. Anti-apoptotic
    • 9.8.3. Mitogenic
  • 9.9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 - 2032
    • 9.9.1. Human
    • 9.9.2. Pig
    • 9.9.3. Mouse
    • 9.9.4. Rat
    • 9.9.5. Others
  • 9.10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    • 9.10.1. Pharmaceutical and Biotechnology Companies
    • 9.10.2. Research Centers and Academic Institutes
    • 9.10.3. Contract Research Organizations
  • 9.11. Market Attractiveness Analysis

10. Latin America Growth Factors Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Grade
    • 10.2.4. By Application
    • 10.2.5. By Expression Host System
    • 10.2.6. By Mode of Action
    • 10.2.7. By Species Origin
    • 10.2.8. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
    • 10.4.1. Transforming Growth Factors (TGF)
      • 10.4.1.1. Activin
      • 10.4.1.2. Bone Morphogenetic Proteins (BMPs)
      • 10.4.1.3. TGF-beta Proteins
    • 10.4.2. Epidermal Growth Factors (EGFs)
    • 10.4.3. Platelet-derived Growth Factors (PDGFs)
    • 10.4.4. Fibroblast Growth Factors (FGFs)
    • 10.4.5. Insulin-like Growth Factors (IGFs)
    • 10.4.6. Vascular Endothelial Growth Factors (VEGFs)
    • 10.4.7. Hepatocyte Growth Factors (HGFs)
    • 10.4.8. Tumor Necrosis Factors (TNFs)
    • 10.4.9. Interleukins
    • 10.4.10. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 - 2032
    • 10.5.1. GMP Grade
    • 10.5.2. NON-GMP Grade
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 10.6.1. Oncology
    • 10.6.2. Hematology
    • 10.6.3. Wound Healing
    • 10.6.4. Dermatology
    • 10.6.5. Cardiovascular Disease and Diabetes
    • 10.6.6. Cell Therapy and EX-vivo Manufacturing
    • 10.6.7. Others
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 - 2032
    • 10.7.1. Animal-derived
    • 10.7.2. Recombinant
  • 10.8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 - 2032
    • 10.8.1. Angiogenic
    • 10.8.2. Anti-apoptotic
    • 10.8.3. Mitogenic
  • 10.9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 - 2032
    • 10.9.1. Human
    • 10.9.2. Pig
    • 10.9.3. Mouse
    • 10.9.4. Rat
    • 10.9.5. Others
  • 10.10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    • 10.10.1. Pharmaceutical and Biotechnology Companies
    • 10.10.2. Research Centers and Academic Institutes
    • 10.10.3. Contract Research Organizations
  • 10.11. Market Attractiveness Analysis

11. Middle East & Africa Growth Factors Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Grade
    • 11.2.4. By Application
    • 11.2.5. By Expression Host System
    • 11.2.6. By Mode of Action
    • 11.2.7. By Species Origin
    • 11.2.8. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
    • 11.4.1. Transforming Growth Factors (TGF)
      • 11.4.1.1. Activin
      • 11.4.1.2. Bone Morphogenetic Proteins (BMPs)
      • 11.4.1.3. TGF-beta Proteins
    • 11.4.2. Epidermal Growth Factors (EGFs)
    • 11.4.3. Platelet-derived Growth Factors (PDGFs)
    • 11.4.4. Fibroblast Growth Factors (FGFs)
    • 11.4.5. Insulin-like Growth Factors (IGFs)
    • 11.4.6. Vascular Endothelial Growth Factors (VEGFs)
    • 11.4.7. Hepatocyte Growth Factors (HGFs)
    • 11.4.8. Tumor Necrosis Factors (TNFs)
    • 11.4.9. Interleukins
    • 11.4.10. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 - 2032
    • 11.5.1. GMP Grade
    • 11.5.2. NON-GMP Grade
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 11.6.1. Oncology
    • 11.6.2. Hematology
    • 11.6.3. Wound Healing
    • 11.6.4. Dermatology
    • 11.6.5. Cardiovascular Disease and Diabetes
    • 11.6.6. Cell Therapy and EX-vivo Manufacturing
    • 11.6.7. Others
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 - 2032
    • 11.7.1. Animal-derived
    • 11.7.2. Recombinant
  • 11.8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 - 2032
    • 11.8.1. Angiogenic
    • 11.8.2. Anti-apoptotic
    • 11.8.3. Mitogenic
  • 11.9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 - 2032
    • 11.9.1. Human
    • 11.9.2. Pig
    • 11.9.3. Mouse
    • 11.9.4. Rat
    • 11.9.5. Others
  • 11.10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    • 11.10.1. Pharmaceutical and Biotechnology Companies
    • 11.10.2. Research Centers and Academic Institutes
    • 11.10.3. Contract Research Organizations
  • 11.11. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Thermo Fisher Scientific, Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Merck KGaA
    • 12.3.3. Bio-Rad Laboratories, Inc.
    • 12.3.4. Lonza Group AG
    • 12.3.5. F. Hoffmann-La Roche Ltd.
    • 12.3.6. Sartorius CellGenix GmbH
    • 12.3.7. Bio-Techne Corporation
    • 12.3.8. GenScript
    • 12.3.9. Miltenyi Biotec.
    • 12.3.10. Abcam PLC
    • 12.3.11. Sino Biological Inc.
    • 12.3.12. Cell Signaling Technology, Inc.
    • 12.3.13. ACROBiosystems
    • 12.3.14. Becton, Dickinson, and Company
    • 12.3.15. Creative Bioarray
    • 12.3.16. Applied Biological Materials (abm) Inc.
    • 12.3.17. GE Healthcare
    • 12.3.18. Meridian Bioscience Inc.
    • 12.3.19. Repligen Corporation
    • 12.3.20. Aviva Systems Biology Corporation (GenWay Biotech)
    • 12.3.21. Leadgene Biomedical, Inc.
    • 12.3.22. Boster Bio
    • 12.3.23. Prospec-Tany Technogene Ltd.
    • 12.3.24. Proteintech Group, Inc.
    • 12.3.25. AJINOMOTO CO., Inc.
    • 12.3.26. STEMCELL Technologies
    • 12.3.27. Akron Biotech
    • 12.3.28. PeproTech Inc.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!